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ABSTRACT 
Ten people with multiple sclerosis (MS) who felt they had cognitive 
difficulties because of their MS were investigated. This study had 
multiple aims. Firstly, to explore the subjective experience of 
cognitive deficits. Secondly, to assess whether or not there was 
objective evidence of cognitive difficulties on neuropsychological 
testing, and whether this was conunensurate with a pattern of 
subcortical dementia. Thirdly, to determine whether their magnetic 
resonance imaging (MRI) scans replicated the patterns of atrophy 
frequently reported in MS patients with cognitive difficulties. 
And finally, to investigate the psychological well-being of the 
subjects . In depth neuropsychiatric interviews, psychiatric and 
psychological inventories, a comprehensive neuropsychological 
battery, and MRI investigations were done. 
The mean Full Scale Intelligence Quotient ( FSIQ) fell within the 
superior range, at the 89th percentile. On t e sts of general 
intelligence, mental state examinations, there was little or no 
indication of cognitive deterioration. However, on sophisticated 
neuropsychological testing, there was convincing evidence of 
cogni tive problems. Magnetic resonance imaging lesions were 
atypical of the reported research on cognitively compromised MS 
patients. 
The striking feature of this research was the anxiety and stress 
associated with the neuropsychological tests, and the subjects ' 
uncertainty in regard to their own subj ecti ve experiences of 
cognitive difficulties. Most of the subjects struggled to 
legitimize their experience of cognitive deficits to themselves and 
to others, and most subjects were experiencing chronic stressful 
circumstances, both related and unrelated to their cognitive 
difficulties. Anxiety and dysthymia, was confirmed on the Millon 
Clinical Multiaxial Inventory - II (MCMI-II), with subjects' mean 
scores in the clinically elevated ranges. Acknowledgement and 
anxiety management should be important components of any cognitive 
retraining and psychosocial intervention programme. 
for future research are provided. 
Suggestions 
CON TEN T S 
Title Page ................... ...................... ... .. i 
Acknowledgements ....................................... ii 
Abstract .......... .......... . ................... . .. ... iii 
Contents Page ................................•.......... v 
Chapter One: 
Literature Review ....................................... 1 
Chapter Two: 
Methodology ...•........................................ 21 
Chapter Three: 
Resul ts: ........................... . ......... ...... .. .. 40 
Chapter Four: 
Discussion and Conclusion .............................. 57 
References ............................................. 75 
Appendices: 
Appendix I: List of Abbreviations 
Appendix II: Neuropsychiatric Questionnaire 
List of Tables 
Table 1: The Subjects ................................. 23 
Table 2: Brain MRI Scoring Criteria .... ...... .. . ...... 38 
Table 3: Screening Measures ........................... 44 
Table 4: Tests of Psychological Well-being ............ 45 
Table 5: Other Indices of Mental Status ............... 46 
Table 6: SAWAIS Results ............................... 48 
Table 7: Tests of Attention ........................... 49 
Table 8: Tests of Memory .............................. 51-53 
Table 9: Tests of Language ............................ 54 
Table 10: Tests of Abstract / Reasoning Ability ..... ... .. 55 
Table 11: Tests of Handmotor Dexterity ................. 55 
Table 12: MRI Results .. .. ........ .... ... ... . ... ........ 56 
List of Diagrams 
Diagram 1: A Multifactorial Aetiology ................... 7 
1 
Chapter One 
LITERATURE REVIEW 
1.1. INTRODUCTION 
Multiple sclerosis (MS) is a disease of 
affecting the central nervous system (CNS ). 
li terature has concentrated on the physical 
unknown aetiology, 
Historically, the 
sequelae of this 
chronic, demyelinating disease. It is only recently that research 
has begun into the cognitive aspects, despite the fact that mental 
changes were recognized from the earliest accounts (Rao, Reingold, 
Ron, Lyon-Caen & Comi, 1993) . 
Attention to cognition in MS has been neglected for several 
reasons . Firstl y, cognition has traditionally been viewed as a 
function of the cortex (Prosiegel & Michael, 1993 ) and cortical 
structures are rarely directly involved in MS (Mendozzi, Pugnetti, 
Saccani & Motta, 1993). It is only recently that white matter 
disease has been implicated in cognitive function. Secondly, 
inconsistent findings have complicated a clear understanding of 
cognitive impairment in MS. Furthermore, the image of many MS 
patients being 'neurotic ' (and thus cogni t ive symptoms can be 
viewed as imag i ned) has also added to the minimalization of 
cognitive dysfunction in MS ~ Lastly, as depression is common in 
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MS, cognitive symptoms can be misdiagnosed as a psuedodementia. It 
is only with the recent advent of sophisticated neuropsychological 
and neuroimaging techniques that cogni ti ve dysfunction can be 
systematically studied. 
The debate as to whether affective disorders and cognitive 
dysfunction are reactions to having MS, or directly caused by the 
demyelination, or the coincidental occurrences of separate illness 
(e.g., bipolar affective disorder) (Honer, Hurwitz, Li, Palmer & 
Paty, 1987), is ongoing. Affective disorders, fatigue and 
cognitive disturbance in MS are equally important to understand, as 
they can all influence (even cause) each other. 
1.2. PSYCHIATRIC IMPLICATIONS 
1.2.1. Anxiety and Neurosis 
Multiple sclerosis patients often present with inexact symptoms, 
with "no" physical cause (Smith, Samkoff & Scheinberg, 1993), and 
people with MS are frequently misdiagnosed (Feinstein, Du Boulay & 
Ron, 1992b) . In a study of 91 patients with MS, 16% were referred 
for psychiatric treatment between the onset of initial symptoms, 
and their diagnosis of MS (Minden & Schiffer, 1993). These figures 
were repeated in the study by Skegg, Corwin and Skegg ( 1988). 
Research shows that patients can welcome their diagnosis (O ' Connor, 
Detsky, Tansey & Kucharczyk, 1994), as, for many, it was a relief 
to know that they could dismiss "often unexpressed fears of 
madness, brain tumours and 'making it all up'" (W. B. Mathews, 
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Acheson, Batchelor & Weller, 1985, p. 262). 
The difficult y of the diagnosis, unpredictability of the illness 
trajectory, lack of a cure, and the significance of loss, make it 
imperati ve to understand the psychological dimensions of this 
disease. Despi te the minor part it is likely to play (Ron & 
Feinstein, 1992), the role of stressful events in precipitating 
relapses is frequently reported, and adds to an image of the 
neurotic patient (Skegg et al., 1988). Doctors may be taught to 
expect that patients with mild MS may become incapacitated by non-
organic symptoms and that this is possibly a form of neurosis 
(Boyle, Clark, Klonoff, Paty & Oger, 1991; W. B. Mathews et al., 
1985). Doctors may also be taught that, although rare, MS may 
present with an acute onset of psychotic symptoms. 
1.2.2. Psychosis 
Feinstein et al . (1992b) assessed ten MS patients with psychotic 
illness. Compared to non-psychiatrically disturbed MS controls, 
there was a tendency for higher total lesion score - particularly 
around the periventricular areas and the temporal horn. In 
addition, the MS patients had a later age of onset of psychosis 
than in the schizophrenic · population, typical of mental disorders 
due to a general medical 
Association (APA), 1994). 
condition (American Psychiatric 
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1.2.3. Euphoria 
The most frequently assumed psychiatric manifestation of MS is 
euphoria. However, research figures vary markedly; from 0 - 84% 
for euphoria (Boyle et al., 1991, p. 1154), and 7% 95% for 
pathological laughing and weeping (Prosiegel & Michael, 1993). 
Furthermore, there is no consensus as to its cause (Sanders & Van 
Lieshout, 1992). Euphoria could mask a major depressive episode 
(Burnfield, 1991), or it could be associated with the focal effects 
of frontal lobe white matter disease (Arnett et al., 1994). 
1.2.4. Depression 
At any current time, between 14% - 57% of MS patients suffer from 
depression (Minden & Schiffer, 1993). Different chronic medical 
diseases may have a distinctly different impact on quality of life 
(Rudick, Miller, Clough, Gragg & Farmer, 1992). Both psychological 
reactions and direct disease activity are implicated in the 
aetiology of depression in MS. 
People with MS often need to deal with unpredictable (even daily) 
fluctuations of their symptoms. On average, 60% are unemployed 
within 10-15 years of onset, 40% spend most of their day alone, and 
53-72% suffer significant marital discord (Minden & Schiffer, 1993, 
p. 36). Considering the concomitant stresses associated with the 
illness, many consider depression a normal psychological reaction 
to MS (and, as such, it is often ignored or left untreated). 
However, when compared to people 
illnesses or disabling conditions 
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suffering from other medical 
(e.g., spinal cord injury), 
people with MS experience significantly more affective disturbances 
(Minden & Schiffer, 1993). This supports the possibility that 
demyelination plays a significant role. Furthermore, where the 
disease primarily involves cerebrum lesions, then the rate of 
depress ion in MS patients is much higher than with spinal cord 
lesions. Other factors, such as drugs used in the treatment of MS 
exacerbations (Acorn & Anderson, 1990; Siblerud, 1992), can also 
contribute to affective disorders. 
1.2.5. Depression and Cognition 
Whatever the cause, depression is common in MS and may invalidate 
assessments of cognition (e.g., via low motivation, slowed thinking 
and poor concentration) (Sandroni, Walker, Tech & Starr, 1992; 
Minden & Schiffer, 1990a). Gilchrist and Creed (1994) ascertained 
depression to be associated with significant cognitive impairment. 
The opposite may also occur, where depression inventories can be 
confounded by poor cognition (e.g., reduced insight) or other MS 
symptoms (e.g., fatigue). 
Minden, Moes, Orav, Kaplan and Reich (1990b) determined that 
medication 
Conversely, 
has an impact 
many researchers 
on cognitive test performance. 
(Rao, 1993; Ron, Callanan & 
Warrington, 1991) determined medications and mood disorder 
contributed minimally in explaining the cognitive problems found in 
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MS. The discrepant findings have led to differing emphasis being 
placed on psychiatric status and medications. Although generally, 
antidepressant medication is not considered grounds for exclusion 
(Grigsby, Ayarbe, Kravcisin & Busenbark, 1994), pharmacological 
influences on neuropsychological testing should first carefully be 
, 
gauged. Without such an appraisal, one cannot accept the validity 
of test results. Besides depression and medication, fatigue can 
also affect cognitive ability . 
1.3. FATIGUE 
Fatigue, a symptom common to both depression and multiple sclerosis 
(Buelow, 1991; Feinstein, Kartsounis, Miller, Youl & Ron, 1992a), 
influences cognitive functioning. Patients with chronic fatigue 
syndrome also show significant impairment on tasks of complex 
concentration and information processing ability (DeLuca, Johnson, 
& Natelson, 1993). However, like depression and cognitive 
dysfunction, fatigue may also be due to specific lesion sites 
(Clarketal.,1992) . 
In summary, the labyrinthine interaction of these variables make a 
mul tifactorial aetiology of cognitive difficulties in MS most 
likely. Depression, anxiety, cognitive dysfunction and fatigue may 
be independent symptoms of MS. Depression, anxiety and fatigue may 
cause reversible cognitive symptoms, or may be secondary to, 
cognitive impairment. (See Diagram 1.) 
Diagram 1: A MULTIFACTORIAL AETIOLOGY 
A MULTIFACIQlllAL AETIQLQGY~ 
MULTIPLE SCLEROSIS 
1.4. COGNITIVE DEFICITS 
1.4.1. Prevalence 
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Depending on the sample selected, figures of cognitive impairment 
differ markedly (Feinstein et al., 1992a; Ha1breich, 1993). 
According to Rao, Leo, Bernardin and Unverzagt (1991a), 
approximately 50% 65% of patients attending MS clinics are 
cognitively impaired. 
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Prevalence rates for relapsing-remitting 
(RR) MS patients tend to be between 25% and 35%, although results 
have ranged from 10% to 60% (Pugnetti et al., 1993, p. S64), while 
up to 60% - 70% of chronic progressive (CP) MS patients show 
pathological results on psychometric tests. It is estimated that 
approximately 40% 45% of the entire MS population have some 
degree of cognitive dysfunction (Grafman, Rao, Bernardin & Leo, 
1991). 
Al though statistics differ, it is generally agreed that South 
Africa has a low prevalence of MS (Thornton & Lea, 1992), with 0.4 
per 100 000 per annum diagnosed in South Africa (W. B. Mathews et 
aI., 1985). Multiple Sclerosis is rare among indigenous Black 
people within Southern Africa and uncommon in people previously 
classified as "Coloured" and Indian (Dean et aI., 1994). 
1.4.2. Subcortical dementia and MS 
Cognitive fall-off may be subtle and variable. Due to the unique 
nature of MS pathology, and the uncertainty regarding the effects 
of disseminated demyelination of white matter on cognitive 
function, MS patients may show atypical cognitive deficits. As 
these deficits may not be concordant with current conceptions of 
brain-behaviour relationships (Ryan et aI., 1993), they may be 
overlooked. Al though cortica}.. atrophy in the pathogenesis of 
cognitive disturbance in MS cannot be completely ruled out 
(Pozzilli et al., 1993), it is cortical suppression or 
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deactivation, secondary to disconnection from subcortical 
structures, that remains the best current explanation for cognitive 
deficits in the illness (Honig, Ramsay & Sheremata, 1992). 
Multiple sclerosis affects a wide array of cognitive domains, with 
recent memory, sustained attention, information processing speed, 
abstract thinking, visuospatial skills and verbal fluency 
L-
frequently reported as impaired (Comi et al., 1993; Minden, 1990b; I 
Rao, St Aubin-Faubert & Leo, 1989b). Immediate memory, recognition 
memory, language functions and general intelligence appear to 
remain relatively intact (Rao, 1993). The general consensus is 
that this pattern of cogni ti ve decline in MS is a subcortical 
dementia, similar to the pattern of subcortical dementia found in 
Parkinson ' s Disease, Huntington Disease and progressive 
supranuclear palsy (Horton & Siegel, 1990; Jennekens-Schinkel, Van 
der Velde, Sanders & Lanser, 1990b). This differs from the 
cortical dementias (e.g., Alzheimer's disease) where intellectual 
decline is a result of amnesia, agnosia and aphasia (Rao, 1993). 
1.4.3. Conflicting Results 
Understanding cognitive functioning in MS is hampered by the 
variable research findings. For example, verbal memory impairments 
were found in some studies (DeLuca, Barvieri-Berger & Johnson, 
1994), but not in others (Ron et al., 1991). Rao, Leo, and St . 
Aubin-Faubert (1989c) suggested immediate memory to be intact, 
while Grigsby et al. (1994) deduced immediate memory to be 
impaired. 
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Arnett et al. (1994) described definite links between 
frontal lobe white matter involvement and conceptual reasoning 
skills. However, Beatty (1993) found no convincing evidence that 
conceptual functions were causatively associated with frontal lobe 
lesions in MS patients. And while many researchers (Kessler, 
Cohen, Lauer & Kausch, 1992; Rao, 1993) claim general intellectual 
functioning to be preserved, others (Canter (1951) cited in Rao, 
1986; Ron et al., 1991) found evidence of intellectual decline. 
1.5. METHODOLOGICAL PROBLEMS 
Discrepant findings on the cognitive nature of MS is in part due to 
the considerable variation in methodology and sample selection, 
thus hindering the pooling of data (Peyser, Rao, LaRocca & Kaplan, 
1990). Biased sampling, small sample sizes, differing diagnostic 
criteria, inappropriate or no controls, divergent psychometric 
assessments, and lack of longitudinal studies, are frequent 
methodological flaws. 
1.5.1. Heterogeneity 
The most obvious difficulty in research into this illness is its 
heterogeneity. Symptomatology for each patient can fluctuate, and 
symptoms between patients can be markedly different in nature, 
severity and course. Biased sample selection often under-
represents patients with a benign course of MS, and MS patients who 
are institutionalized, or unable to tolerate testing due to severe 
motor I sensory impairment, are seldom included in research ( Rao et 
al., 1991a). 
1.5.2. Age and education 
In many studies, subjects' 
for, and few (Ryan et 
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ages and education are not controlled 
al., 1993) place an age limit on 
participants. Thus older or relatively uneducated patients could 
be classified as cognitively impaired when they are functioning 
close to their premorbid level (Rao et -al., 1989a). Conversely, in 
highly educated subjects, performance at the norm for the general 
population, may be indicative of cognitive decline. Kessler et al. 
(1992) and Jennekens-Schinkel et al. (1990b) found highly educated 
subj ects to have inflated performances on memory and learning 
tests. Similarly, socio-economic status has been attributed as a 
confounding factor (Minden et al., 1990b). Widespread low 
education and lack of standardized tests make cognitive assessment 
problematic in South Africa. 
1.5.3. Control groups and longitudinal studies. 
Mul tiple sclerosis is a unique neurological disorder, and its 
fluctuating, unpredictable nature makes it difficult to find an 
ideal comparison group. Consequently, in most research into MS and 
cogni tion, there is a conspicuous lack of control groups. If 
controls are used, then elementary sensory and motor requirements, 
psychiatric status and medication should ideally be controlled for, 
both wi thin and between groups. However, the most appropriate 
investigation into cognitive impairment is the longitudinal study. 
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Few longitudinal studies exist (Jennekens-Schinkel, Laboyrie, 
Lanser & Van der Velde, 1990a; Mariani et al., 1991). Seldom can 
a direct comparison be made between a patient's premorbid and 
postmorbid test performance, and decline must be based on 
assumptions of premorbid functioning. Canter (1951) (cited in Rao, 
1986) obtained the Army General Classification Test intelligence 
scores for 32 males who were healthy at the time they entered the 
mili tary, but later developed symptoms of MS. Readministered 
approximated four years later, the same test revealed a mean drop 
of 13.5 intelligence quotient (IQ) points. 
The predominant failing of most longitudinal studies, has been 
their small sample size (Arnett et al., 1994; Feinstein, Ron & 
Thompson, 1993). Even when practice effects are taken into 
account, the natural history of cognitive deficit in MS is highly 
variable, and in fact, improvement over time is possible. 
1.6. FACTORS PREDICTIVE OF COGNITIVE DYSFUNCTION IN MS 
It remains uncertain what factors are predictive of cognitive 
dysfunction in multiple sclerosis. Factors such as duration of the 
illness, degree of physical disability and type of MS have been 
extensively researched to determine their impact on cognit i ve 
functioning. 
1.6.1. Duration of the illness 
Many researchers have concluded that the cognitive symptoms in MS 
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do not appear to be linked with duration of the illness. 
Significant dementia can occur early on in the disease (W. B. 
Mathews, 1979; Ron et al., 1991) even before there are sufficient 
neurological symptoms for a diagnosis (Rao, 1993). However, other 
research has associated cogni ti ve dysfunction with an advanced 
disease state (Ron et al., 1991; Smith et al., 1993). 
1.6.2. Degree of physical disability 
Several studies (Kessler et al., 1992; McIntosh-Michaelis et al., 
1991) have determined cognitive impairment to be associated with 
physical disability. Conversely, Beatty, Goodkin, Hertsgaard and 
Monson (1990a) did not find physical disability to be related to 
cognitive performance, and patients with only minimal physical 
impairments can have cognitive dysfunction severe enough to limit 
daily activities significantly (Beatty & Goodkin, 1990b). The 
gravity of physical disability should not be underestimated. 
Severe motor, sensory and visual deficits can interfere with the 
validity of certain neuropsychological tests, and fatigue and pain 
can result in problems with attention and memory. 
1.6.3. Type of MS: Relapsing-remitting versus chronic progressive 
When compared to healthy controls, even people with mild MS, and MS 
in remission still tend to have some cognitive dysfunction 
(Klonoff, Clark, Oger, Paty & Li, 1991). However, often it is only 
with sophisticated neuropsychological tests that such impairment 
can be detected in functionally independent RR MS patients (Ryan et 
al., 1993). 
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In their study of 41 MS patients with mild overal l 
functional impairment, Anzola et al . (1990) established very mild 
cognitive impairment. By selecting patients with a RR course of 
MS, they may have excluded the majority of patients with MS-related 
dementia. Pugnetti et al. (1993) concluded the typical prevalence 
of cognitive impairment in RR patients to be about 31%. 
Some research suggests that the chronic-progressive course in MS 
produces more cognitive symptoms than the RR course (Comi et al., 
1993; Kessler et al., 1992; Mariani et al., 1991). But these 
findings have been unsupported by other researchers (Beatty et al. , 
1990a; Jennekens-Schinkel et al., 1990b). While research findings 
differ, it is also suggested that cognitive impairment in MS is 
strongly associated to the amount of cerebral involvement on 
Magnetic Resonance Imaging (MRI). 
1.7. ADVENT OF NEUROIMAGING TECHNIQUES 
In recent years, due to the advent of sophisticated neuroimag i ng 
techniques, the in vivo evaluation of lesions is now possible . 
Since 1981, the MRI has contributed to the diagnostic certainty of 
the disease (Goodkin, Rudick & Ross, 1994). 
Again, research is troubled by differing methodological approaches. 
Anatomical markers and interresearcher procedures are 
unstandardized (Swirsky-Sacchetti et al., 1992) . Field strengths 
in MRI magnets differ, as do evaluations of brain MRI films ( Comi 
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et al., 1993). Most methods of quantifying lesions have only been 
crude approximations (Ron et al., 1991), and there are differing 
methods of estimating lesion volume (Feinstein et al., 1992b). 
Despite these limitations, the MRI remains a sensitive tool for in 
vivo evaluation as direct evidence of disease activity can be 
monitored without invasive procedures. 
1.7.1. Magnitude versus spread of lesions 
Global cogni ti ve 
Lesion Area (TLA). 
TLA ranges from 
deterioration is often associated with Total 
It is generally postulated that if the minimum 
20 30 square centimetres, then cognitive 
dysfunction is more likely to occur. Izquierdo, Campoy, Mir, 
Gonzalez and Martinez-Parra (1991) found patients with MRI lesions 
over 2000 square millimetres in the periphery of the lateral 
ventricles, to perform significantly worse on tests of memory, 
learning and acquisition. Arnett et al. (1994) also determined 20 
square centimetres to be significant. On the more conservative 
side, Ron et al. (1989c) established the significant TLA to be 30 
square centimetres. And Swirsky-Sacchetti et al., (1992), 
ascertained TLA for their cogni ti vely impaired group to average 
28.30 square centimetres, whereas for the unimpaired group, the 
mean was 7.41 square centimetres. 
Depending on their location, some focal lesions can result in 
specific cognitive and neuropsychiatric deficits (Prosiegel & 
Michael, 1993). Even early in the disease, selective cognitive 
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deficit can result from lesions which happen to interrupt fibre 
tracts subserving specific functions (Comi et al., 1993). It is 
likely that both volume and location of MS lesions can play 
significant roles in cognitive function, and that an interplay 
between the two is the most likely. 
1. B . THE MRI AND COGNITIVE SYMPTOMS 
Since 1987, MRI lesions have been correlated with 
neuropsychological impairments (Goodkin et al., 1994), providing 
new insight into the pathogenesis of cognitive dysfunction in MS. 
Commonly, TLA, lesion location, ventricular dilatation and regional 
changes in cerebral physiology are determined in correlating MRI 
brain changes with cogni ti ve test performance (Rao, 1993). In 
other studies, summed length of the individual plaques' longest 
diameters (Ron et al., 1991), and left versus right hemispheric 
involvement (Anzola et al., 1990) are used. 
Overall lesion burden tends to be associated with cognitive 
deficit, periventricular lesions with verbal memory deficits, 
bilateral hippocampal lesions with recent memory difficulties (Rao, 
1993), and prefrontal cortex atrophy can be associated with working 
memory difficulties (Grigsby et al., 1994). Arnett et al. (1994) 
associated frontal lobe lesions with conceptual reasoning deficits 
and perseverative responses. 
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1.8.1. The corpus callosum and interhemispheric disconnection 
Characteristically, MS patients have corpus callosal involvement . 
The corpus callosum (CC) is a prominent band of compact white 
matter and the major axonal commissure of the brain, connecting the 
two cerebral hemispheres (Georgy, Hesselink & Jernigan, 1993). 
Sustained attention, mental processing speed and rapid problem 
solving are dependent on precisely timed interhemispheric 
communication (Goodkin et al., 1994; Rao et al. 1989a), and thus MS 
is a particularly useful model of interhemispheric disconnection 
(Schnider, Benson, & Rosner, 1993). Pelletier et al. (1993) 
proposed the CC could play a role in cognitive and behavioural 
impairment, and Rao's (1993a) described slowed word naming if items 
were in the left visual field. 
Recent evidence exists for sex- and handedness-related variations 
in callosal size (Pozzilli et al., 1991a). Georgy et al. (1993, p. 
949) reported that in some research there is a larger main callosal 
area in men, and an 18-28% increase in the main callosal area in 
persons with right hemispheric cerebral speech dominance. However, 
Pelletier et al. (1993) determined no significant effect or 
interaction on these variables. Sex- and handedness-related 
variations remain controversial, and as yet it is not known how 
this affects people with MS. 
1.8.2. Ventricular dilatation 
Dilatation in MS generally relates to demyelination (i.e., atrophy) 
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of the surrounding white matter, and reflects pathological changes 
in the periventricular regions. Thus evaluating the degree of 
ventricular dilatation should be an important variable in all MRI 
research into cognitive symptomatology. 
Ventricular dilatation disrupts periventricular pathways 
interconnecting prefrontal and limbic structures which may explain 
memory and conceptual reasoning deficits. Comi et al. (1993) 
(N=100) ascertained ventricular dilatation and CC atrophy to be 
correlated significantly with low scores on almost all the 
neuropsychological tests. In patients with extensive, irregular, 
periventricular demyelination, Mariani et a1. (1991) found a 
relatively inferior performance on concept formation, non-verbal 
reasoning and verbal memory tests when compared with controls. 
Periventricular and frontal lesions have also been associated with 
"psychologic 
irritability, 
symptoms" 
reduction 
(i.e., depressed or 
of drive and disorder 
euphoric mood, 
of judgement) 
(Reishies, Baum, Brau, Hedde & Schwindt, 1988). 
1.9. SUBJECTIVE EXPERIENCE OF COGNITIVE FUNCTIONING 
Very few MS studies (DeLuca et al., 1993; 
looked at MS patients who subj ecti vely 
R. Taylor, 1990) have 
feel that they suffer 
cognitive symptomatology. Metamemory which refers to a person's 
knowledge about their memory (Beatty, 1993), is an indication of 
how accurately judgements about one ' s own memory can be made . 
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Grigsby et al. (1994), determined patients' complaihts to be 
congruent with their psychometric test findings. 
However, Beatty and Monson (1991) established that MS patients 
tended not to acknowledge test-demonstrable memory deficits, and 
concluded that patient self-reports on memory were likely to be 
unreliable sources of information. And, McIntosh-Michaelis et al. 
(1991), found subtle cognitive changes tended to go unrecognized by 
people with MS, their families or clinicians. It may be that 
patients with moderate to severe cognitive dysfunction may be 
apathetic and loose insight and self-awareness, thus under- or 
over-reporting cognitive symptoms. Alternatively, patients may be 
threatened by cognitive decline, and deny that it is happening. 
Unfortunately, there remains a dearth of research into the area of 
subjective experience of cognitive deficits. Gilchrist and Creed 
(1994) determined 
discrepancy between 
that patients repeatedly emphasized the 
their subjective experience of cognitive 
impairment and the lack of such disability evident to others. 
Especially when cognitive symptoms were variable or unpredictable, 
patients can be labelled as "lazy" or "lacking motivation" (1994, 
p. 200), often causing familial strife. 
1.10. AIMS OF THIS STUDY 
This study investigates ten people with MS who feel they have 
cognitive difficulties because of their MS. It aims to: 
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1.) Explore the subjective experience of cognitive deficits, as 
this is frequently ignored in research. 
2 . ) Investigate the presence of psychological distress in the 
group, as depression and anxiety are frequently associated with the 
illness. 
3.) Assess whether or not there is evidence of cognitive deficits, 
and if there is, if it fits the pattern of a subcortical dementia. 
4.) Determine whether their MRI scans replicate the patterns of 
atrophy frequently reported in cogni ti vely compromised MS patients . 
Neuropsychological tests, psychiatric and personality inventories, 
and MRI investigations were done on each participant to evaluate 
the exact nature of their cognitive deficits (if any). In 
anticipation that confounding aetiological variables may exist, it 
is intended that all the participants will be re-assessed at 5-
yearly intervals, in order to have a longitudinal representation of 
their course of cognitive dysfunction and MS . 
This study does not aim to establish differences between people 
wi th MS and controls (as there is no ideal comparison group). 
Rather, it seeks take a descriptive look at cognition and emotional 
well-being of ten people who subjectively experience cognitive 
defic i ts due to their MS, and how this evolves over time. 
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Chapter Two 
MET HOD 0 LOG Y 
2.1. SUBJECTS 
A letter was sent out with the South African National Multiple 
Sclerosis Society (SANMSS) newsletter explaining the research and 
requesting participants. People who, firstly, believed they 
suffered from cognitive symptoms, and secondly, that these were due 
to their MS, were asked to respond. Forty people replied and were 
initially screened by telephonic interview. The following 
exclusion criteria were applied: 
1.) No subject fifty years or older was included in the study. 
2.) No subject had impairments of sight, hearing or motor 
function of sufficient severity to preclude valid testing. 
3.) No subject was currently a medical or psychiatric inpatient. 
4.) All subjects were fluent in English. 
Some people wanted to talk about MS and cognition, but were 
unwilling to be assessed (N=4), and nine respondents were over 50. 
One person, actively suicidal, was referred on to her doctor for a 
psychiatric referral. Eleven people were provisionally accepted 
into the study. However, one subject had a law suit pending, and 
wanted her neuropsychological test results to be used as evidence . 
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As this could have been interpreted as an invested bias, she was 
excluded from the research after the initial interview and 
screening measures. 
The ten subjects (six women, four men), ranged in age from 27-47 
years. (See Table 1.) Onset of MS symptoms ranged between two and 
19 years, with a mean of 7.3 years since clinical diagnosis. One 
subj ect was wheelchair-dependent, and three were dependent on 
walking aids. All were right-handed. Years previous to the study, 
one subject had had meningitis, one a pulmonary embolism which had 
required resuscitation, and another, two myocardial infarctions. 
Only one subj ect has a history of loss of consciousness (four 
hours), with no post-traumatic amnesia reported. 
Six subjects described a RR, and four a CP course. One subject 
with RR MS had had an exacerbation three weeks prior to his 
assessment. At the time of testing, three subjects were on Prozac 
(Fluoxetine), one was on Tegretol, one on Tenormin (Atenolol), and 
one subject was on Dormican (Midazolam) at night . 
The mean years of education was 16.1. Two of the subjects were 
medical special ists, and four were secretaries or clerks. Half the 
sample were 
computing) or 
self-employed 
assisted a 
(estate 
spouse I 
agency, picture 
partner. Of 
framing, 
the six 
professionals, two no longer worked in their area of discipline, 
and three had had to make adjustments in their initial job 
t--
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description in order to accommodate their symptoms. Nine subjects 
were "White" and one "Coloured". 
Table 1. 
ID 
01 
02 
03 
04 
05 
06 
07 
08 
09 
10 
X 
SD 
Age 
27 
30 
32 
34 
35 
36 
41 
43 
46 
47 
37 . 2 
6.7 
Sex 
F 
F 
F 
F 
F 
M 
M 
M 
F 
M 
QulifictN Years of 
EducatN 
Secretary 
Teacher 
Clerk 
Prograrruner 
Personal Ass. 
Anaethetist 
Urologist 
Engineer 
Estate Agent 
Insurance 
14 
19 
9 
18 
13 
22 
23 
16 
14 
13 
16.1 
4.4 
2.2. PROCEDURE 
No. years 
w SVillOtms 
15 
l4 
19 
6 
10 
13 
13 
18 
17 
2 
12.7 
5.4 
Years since 
Diagnosed 
4 
3 
15 
6 
6 
11 
9 
13 
4 
1 
7.3 
4.6 
Type 
MS 
RR 
RR 
CP 
CP 
RR 
CP 
RR 
CP 
RR 
RR 
Option to wi thd"raw at any time was agreed upon prior to outset, and 
feedback and explanation of individual results were offered. All 
the subjects gave informed consent and permission to contact their 
neurologistS . Subjects were agreeable in principle to being re-
assessed in five yearly intervals for a long-term follow-up study. 
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Frequently , fatigue interferes with the functional status of MS 
patients, and in cognitive assessments. Rao, Leo, Haughton, St. 
Aubin-Faubert and Bernardin (1989a) , and Arnett et al. (1994) 
emphasized the need to limit the length of testing sessions. To 
minimize fatigue, the assessment took place over three testing 
sessions, with each session taking approximately . two hours. 
Subjects were encouraged to take breaks when tired. The second and 
third sessions were all arranged to take place within one week of 
the participant's MRI investigation. Mariani et al. (1991) 
emphasize the need for the minimum of delay between the MRI and 
neuropsychological assessments as MRI modifications may not be 
associated with clinical evidence. 
All subjects underwent further screening measures ( also used for 
analysis), a neuropsychiatric interview, an assessment of anxiety 
and dysthymia, neuropsychological testing and MRI investigations. 
After the completion of the first neuropsychological battery, one 
subject le f t the s t udy due to distressing family problems. The 
neuropsychological tests were scored, with the researcher blinded 
to the MRI results. 
2.3. Screening Questionnaires 
During the first interview, the following screening measures were 
administered : the Rey Fifteen Item Test; the Mini Mental Sta t e 
Examinat i on and the Hamilton Rating Scale for Depression . The Rey 
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Fifteen Item Test (RFIT), may be used to assess the presence of a 
pseudoneurological memory disorder or malingering (Walsh, 1990) . 
The Mini Mental State Examination (MMSE) is a brief screening 
measure for dementia (Folstein, Folstein & McHugh, 1975), and 
served to exclude subjects too cognitively impaired to give 
informed consent. The standard cutoff of 24/30 was used. 
The Hamilton Rating Scale for Depression (HRS) was completed to 
exclude subjects with depression. -Although the HRS is not a 
diagnostic instrument for depression (Hamilton, 1967), it measures 
mood and all the vegetative symptoms of a clinical depression. In 
a longitudinal study it is useful in measuring symptomatic changes 
over time. Research on non-psychiatric populations (Schwab, 
Bialow, Clemmons & Holzer, 1967) demonstrated that a score of 
43/100 for questions one to 17, correlated with the Beck Depression 
Inventory (BDI) and with other depression criteria. In this study, 
a conservative cutoff score of 30 (for questions one to 17) was 
used as a screen for clinical depression. In sununary, the 
following cutoff scores and screening measures were implemented at 
the first interview: 
5.) Cutoff score of 24 / 30 on Mini Mental State Examination . 
6.) Cutoff off 30 on the Hamilton Rating Scale for Depression . 
7.) No signs of malingering in the Rey 15 Item Test . 
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2.4. THE NEUROPSYCHIATRIC INTERVIEW 
Interviews took place at the subjects' homes, and were based on a 
structured and semi-structured questionnaire (see appendix). The 
questionnaire examined personal and family history of neurological 
and psychiatric illness, and the subjects' subjective experience of 
cognitive function. Questions exploring the subjects' definitions 
of "cognitive", what symptoms they experience, why they relate it 
to their MS, and how they compensate, were included. Their 
perception of family members' and neurologists' reactions to their 
"cognitive" symptoms were also recorded. Direct quotes from open-
ended questions were used to provide additional information. 
2.5. NEUROPSYCHOLOGICAL TEST BATTERY 
In this research, tests of general intelligence, attention, memory, 
language, abstract and reasoning ability, and handmotor dexterity 
were included, as these cognitive domains have shown to be 
compromised in MS. 
2.5.1. Tests of General Intelligence 
Subjects completed the South African Wechsler Adult Intelligence 
Scale (SAWAIS). Comi et al. (1993) detected 37% of MS patients 
(N=lOO) to show decline in intelligence. However, visual and motor 
impairment (common in MS), can negatively influence test results. 
This particularly applies to the performance subtests, making the 
Performance Intelligence Quotient (PIQ) susceptible to 
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deterioration. In contrast, the Verbal Intelligence Quotient (VIQ) 
is relatively resistant to impairment in MS (Ryan et al., 1993). 
Thus VIQ is often used as an index of global cognitive performance 
(Arnett et al., 1994), especially when MS patients have visual or 
motor impediments. For this reason, the VIQ and the Full Scale 
Intelligence Quotient (FSIQ) were compared to each other, as was 
PIQ with VIQ. 
All the SAWAIS subtests were administered, except for the 
Vocabulary subtest, due to time constraints. Age-scaled 
standardized scores for each subtest were obtained . In Digit 
Repetition (DR), Digits Forward (DF) and Digits Backward (DB) were 
viewed as separate tests, as they involve different mental 
activities and are affected differently by brain damage (Lezak, 
1983). The difference between DF and DB, Digits Difference (DD), 
should not be greater than two (Lezak, 1983) . 
2.5.2. Tests of Attention 
Attention difficulties are often implicated in MS, whether due to 
anxiety, depression, fatigue or cogni ti ve dysfunction. Digits 
Forward (SAWAIS), commonly assumed to be a test of memory, is more 
closely related to the efficiency of attention, or a test of the 
"passive span of apprehension" (Hayslip & Kennelly, 1980, cited in 
Lezak,1983). The Visual Memory Span (VMS) of the Wechsler Memory 
Scale-Revised (WMS-R) is a sequential block-tapping task which is 
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considered a visuo-spatial equivalent of DR (SAWAIS) (Anzola et 
al., 1990). Digit Repetition tends to be more vulnerable to left 
hemisphere involvement (Lezak, 1983), and VDS more susceptible to 
right hemisphere damage. In this way, by comparing DF (SAWAIS) 
wi th visual DF (VMS, WMS-R), lateralization of function to the 
right and left hemispheres, is possible. 
Originally part of the Army Individual Test Battery, the Trail 
Making Tests (TMT) function as tests of attention, visuomotor 
tracking, coordination, visual scanning, motor speed, and double 
conceptual tracking (working memory). Because the TMT requires 
cogni tive flexibility, it is highly vulnerable to brain damage 
(Lezak, 1983). The TMT is a paper and pencil test. In TMT-A, the 
participant connects 25 consecutively numbered circles randomly 
distributed on a sheet of paper, as rapidly as possible. In TMT-B, 
the participant alternatively connects the numbers and letters (C. 
G. Mathews et al., 1970). Percentile ranks for TMT-A and TMT-B 
were extrapolated from Lezak (1983) (Spangenberg, 1992). 
2.5.3. Memory 
Memory is reportedly the most common cognitive symptom affected by 
MS (Burnfield, 1993) and memory tests, frequently applied to people 
with MS, were included in the battery. 
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2.5.3 .1. Tests of Prospective and Episodic Memory 
People with MS often complain of forgetting tasks that other people 
have asked them to do (Burnfield, 1993), therefore prospective 
memory was assessed. At the begining of the neuropsychiatric 
interview, subjects were asked to remember to do three things at 
the end of the interview (to comment on the weather, to pick up a 
coin, and to undo a button/sleeve). If subjects failed to remember 
this spontaneously, they were prompted. Subjects were also asked 
four episodic memory questions (e.g., "What did you eat last night 
for supper?"; "What was on the news?"; "What did you wear 
yesterday?" ) . 
2.5.3.2. Tests of Working Memory 
Working memory, the temporary storage and processing of information 
necessary for the concurrent performance of a wide range of 
cognitive tasks (Baddeley, 1992), was assessed on Serial Sevens 
(MMSE) , TMT-B, Visual Digits Backward (VDB) (VMS, WMS-R) , DB 
(SAWAIS). Norms for VDB (VMS, WMS-R) were taken from the WMS-R 
manual (Wechsler, 1987). Lateralization of function was again 
looked for in comparing Visual Digits Backward (VMS, WMS-R) with DB 
(SAWAIS) . 
2.5.3 .3. Tests of Auditory Memory 
In their research on cognitive function in MS, Pozzi11i et al. 
(1991b) found the Rey Auditory Verbal Learning Task (RAVLT) to be 
the most sensitive test to elicit memory deficits . This test 
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assesses verbal learning, delayed recall and recognition memory 
(Gilchrist & Creed, 1994). Subjects listen while 15 words (List 
A), are read to them, and thereafter repeat as many as possible. 
Five repetition trials are allowed. 
Trial I subtracted from Trial V represented the number of new words 
learned over the five trials. Norms for trials I to V were taken 
from Wiens, McMinn and Crossen (1988). 
words over the five trials (Savage & 
Normally, people learn five 
Gouvier, 1992). Multiple 
sclerosis patients have tended to perform relatively poorly on the 
first trial, but maintain a normal learning curve (Minden et al., 
1990b) . 
An interference trial (List B) is given after Trial V. In error, 
in this research, the recognition trial was administered 
immediately after the five repetition trials. In the recognition 
trial, subjects must identify the List A words embedded in a list 
of distractors. Normally in most neurological illnesses, patients' 
recognition memory is relatively spared (Binder, Villanueva, 
Howieson & Moore, 1993). Half an hour later, a delayed free recall 
test was administered. 
Two other auditory memory tests were administered. In Logical 
Memory ( LM), a short story was read and then immediate recall 
tested. The delayed recall score was the percent of material 
retained from the initial recall after a 30 minute delay_ A South 
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African version of LM used clinically, based on the WMS-R, was 
used, and the story was scored on the same criteria as the WMS-R 
(Wechsler, 1987). Digit Supraspan (DSS) was measured by the number 
of trials taken for a participant to correctly produce a series of 
digits one longer than their longest string on the DF (SAWAIS), on 
two consecutive trials (Zangwill, 1943). A maximum of ten trials 
was allowed. 
2.5.3.4. Tests of Visual Memory 
Visual equivalents of the auditory memory tasks were applied. A 
new test, the Hopkins Board of Visual Recall (HBVR) was 
administered, to assess visuospatial memory and learning. The 
Hopkins Board is equally divided into nine squares and subjects 
must recall which of nine different pictures belong to which 
square. A maximum of ten trials is allowed for, in which subjects 
must obtain two consecutively correct trials. Like the RAVLT, the 
HBVR consists of learning trials, a 30 minute delayed recall, and 
a recognition task. The recognition task was designed for this 
research, and subjects had to identify the original pictures, which 
lay embedded amongst pictures of similar shape or function. 
Currently, no percentiles are available, but in a group previously 
studied, the mean to criterion was 6.4 trials (De Villiers, 1993). 
Visual supraspan (VSS) was also measured, i. e., the number of 
trials needed to tap out a block longer than their longest forward 
tapping sequence on VMS (WMS-R). This was compared with Digit 
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Supraspan. 
The Rey-Osterrieth Complex Figure (ROCF) was designed by Rey to 
assess perceptual organization and visual memory in brain-damaged 
patients (Rey, 1941, cited in Lezak, 1983), and is used extensively 
as a neuropsychological test (Rosselli & Ardila, 1991). The 
subjects were presented with a complex, multi-component geometrical 
drawing (Pozzi11i et al., 1991b), and required to copy it. As 
executive functions are often implicated in MS (Beatty, 1993), 
special attention was paid to the way the figure was copied, and 
subjects used consecutively different-coloured pens to complete the 
figure. In this way, the participant's ability to conceive, 
organize and execute a plan, were assessed. 
Three minutes after the copy task, and after interference, subjects 
reproduced it from memory. E. M. Taylor's (1959) scoring system, 
adapted from Osterrieth (1944) was used (cited in Lezak, 1983). 
Resul ts were compared with percentile norms adapted from Osterrieth 
(1944) (cited in Lezak, 1983) by Lezak (1983). The ROCF was also 
used as a means to detect praxis alterations (Izquierdo et al., 
1991) . 
As an extension of the Digit Symbol subtest (SAWAIS), Digit Symbol 
Incidental Recall (DSIR) was used as a test of incidental visual 
recall (Kaplan, Goodglass & Weintraub, 1978, cited in Lezak, 1983). 
Subjects were not warned that on the completion of the subtest, 
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they would be required to recall the symbols representative of the 
nine numbers . A recall of seven out of nine, is considered the low 
end of average for normal persons (Lezak, 1983). 
2.5.4. Tests of Language Ability 
In MS, many patients complain of not being able to find words which 
remain at the 'tip of the tongue'. The Renfrew Word Finding 
Vocabulary Scale (RWFVS) is a measure of naming skill (i.e . , 
dysnomia) and word retrieval ability. Subjects were presented with 
59 graded pictures (from "cup" to "castor") to name. Inability to 
name an obj ect, and substitutions (e. g., "it scares birds away" 
instead of "scarecrow") were scored. 
available. 
There are no adult norms 
Subjects were also given two verbal fluency tasks, as many MS 
patients have difficulty in the speed and ease of verbal production 
(Rao, 1993). The Controlled Oral Word Association Test (COWAT) 
assessed the timed production of words after phonemic (C, F, and L) 
cues. Scores were adjusted for age, sex and education, and norms 
taken from Lezak (1983) . Subj ects were also presented with 
semantic cues (towns and animals). Typically, semantic cued word 
associations are easier than phonemic cues (Lezak, 1983), and in 
clinical practice, people normally obtain 15 words per semantic 
category in one minute . 
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2.5.5. Tests of Abstract and Reasoning Ability 
Poor performance on the Wisconsin Card Sorting Task (WCST) has been 
used as an indicator of frontal lobe dysfunction (Beatty & Monson, 
1991). The WCST assesses a variety of higher cognitive abilities 
(e.g., abstraction, rule learning, concept formation, conceptual 
reasoning and cognitive set-shifting) (Mendozzi et a1., 1993). It 
consists of a set of stimulus cards and the subject is required to 
sort them according to one of three attributes in turn (colour, 
shape and number) (Heaton, 1981). As in previous studies in MS 
(Callanan, Logsdail, Ron and Warrington, 1989; Ron et a1., 1991), 
a shortened version of the WCST is used. As with Minden et a1. 
(1990b), the test was terminated after 64 cards were placed, three 
trials achieved, or 50 cards placed without attaining one sort. 
For a normal population, the total number of (any) errors to learn 
the first category, is 13.4 (Heaton, 1981). 
2.5.6. Tests of Handmotor Dexterity 
Neuropsychological batteries on MS must of necessity include tests 
to determine the effects of slowed handmotor functions and 
dexterity. Not to do so, would implicate the validity of other 
timed tests such as Trail Making and Digit Symbol (SAWAIS). The 
Grooved Pegboard Test (GPT) is a manual dexterity task (C. G. 
Mathews & K10ve, 1964). The GPT is a metallic board, four inches 
square, with five rows of five holes, each with a differently 
positioned slot, and the patient (using one hand at a time) must 
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fill each slot, horizontally in order, as quickly as possible 
(Kessler et al . , 1992). In order to be inserted accurately, the 
pegs must first be rotated properly. 
minutes is allowed for. 
A cut-off time of five 
Compared to most pegboards, this test requires more complex visual-
motor co-ordination. Some research (Kessler et al . , 1992) found 
the GPT successfully predicted performance on a number of memory 
tasks. Norms were based on the manual produced by Lafayette 
Instrument Company (1989). 
2.6. ASSESSING ANXIETY AND DYSTHYMIA 
Given the frequent reports of depression and anxiety in MS, and 
given that they may influence neuropsychological test results, it 
is of fundamental importance to assess the psychiatric status and 
psychological well-being of the subjects . 
Subjects completed the Millon Clinical Multiaxial Inventory (MCMI) 
- II personality inventory. The MCMI-II investigates a wide range 
of psychopathology, whether long-standing, acute or symptomatic 
clinical syndromes (Wetzler, 1990). The MCMI was originally not 
designed for, nor standardized on non-psychiatric populations, but 
a Base Rate Score (BRS) of 35 is expected as the median score for 
"normal" or nonpsychiatric populations (Choca, Shanley & Van 
Denburg, 1992). However, research has shown that normals can score 
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on pathological levels (i.e., elevations of 75 and over), implying 
overpathologization of certain personality features (Wetzler, 1990, 
p. 458). For this reason, specific attention was paid to the 
scales of Anxiety, Dysthymia, and Major Depression, and not to 
personality profiles. 
The MCMI-II was selected because, besides long-standing syndromes, 
it is sensitive to clinical states (e.g., anxiety) which fluctuate 
over time (Wetzler, 1990). In this way the MCMI is an excellent 
tool to pick up the degree to which mood state can affect a 
person's cognitive test performance. 
Finally, subjects completed the General Health Ouestionnaire (GHQ) 
which measures anxiety, social dysfunction, somatic complaints and 
depression (Acorn & Anderson, 1990), and has been used in MS 
research (Ron et al., 1991). Subjects score changes over the 
previous weeks ("much worse than usual " , "worse than usual", "same 
as usual", or "better than usual"). While no cutoff point was 
employed in this research, the GHQ was used as a measure of acute 
changes or chronicity in mental health and attitudes. 
2.7. MRI INVESTIGATIONS 
Magnetic Resonance Imaging studies were performed with a 
superconducting (version 5.5) Tesla magnet (Elscint Unit with Gyrex 
V.D.L.X.) . In all cases, axial and sagittal planes, with a spin 
l 
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echo sequence (SE) of 2600 / 20 and SE 2600 / 90 were used . After 
the first two subjects, coronal SE 2600 /20 and SE 2600 / 90 were 
added . Proton density (PD) and T2 imaging were used to score the 
plaques . The summed diameter of all the plaques - or total plaque 
diameter (TPD) - and total number of lesions (TNL) were calculated. 
These results were also scored for the right versus the left 
hemispheres; right and left hemisphere's total plaque diameter (RPD 
and LPD), and the number of lesions (RNL and LNL). The degree of 
CC atrophy and the degree of ventricular dilatation were scale-
scored as shown in Table 2. A note was made as to whether plaques 
occurred in the brain stem. Although neuropsychology is generally 
little concerned with the brain stem (Walsh, 1990, p . 52), lesions 
here can affect the patient ' s ability to concentrate if the level 
of arousal is impaired. 
If subjects had previous MRI material available, then comparative 
assessments were made. Each subject's MRI scan was examined and 
scored by a neuroradiologist, who was blinded to the test results. 
Attention was paid to the degree of ventricular dilatation, corpus 
collasol atrophy, and total accumulative plaque diameter. This was 
compared with the MRI findings from other research on cognitively 
impaired MS subjects. 
TABLE 2 
BRAIN MRI SCORING CRITERIA 
(a) Degree of corpus callosum atrophy / ventricular 
dilatation (cerebral atrophy) 
score 0 = no atrophy 
score 1 = mild atrophy 
score 2 = mild to moderate atrophy 
score 3 = moderate atrophy 
score 4 = moderate to severe atrophy 
score 5 = severe atrophy 
(b) Site of corpus callosum atrophy 
score 0 = no atrophy 
score 1 = anterior 
score 2 = body 
score 3 = posterior 
score 4 = whole of CC showing atrophy 
2.8. ANALYSIS OF DATA 
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Small sample size (only eight people had MRI scans), placed 
limitations on the way the data could be statistically analyzed, 
with the probability of obtaining a Type II error very high 
(Howell, 1989). For this reason, there was a concentration on 
descriptive statistics. 
As no control group was employed, where possible the performance of 
each participant on each neuropsychological test was compared with 
normative data. The most relevant normative data was selected, and 
in some instances, age- and education-related norms were available. 
Subjects's scores on individual tests were converted to percentile 
ranks, and compared with their general intelligence (also scored as 
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percentiles). While general impairment can be defined as a score 
at or below the fifth percentile of age- and education-matched 
controls (Beatty & Goodkin, 1990b), here impairment was based on 
self-comparison to general intellectual function. In this way, 
effects of age and education were also accounted for. 
When the median differed markedly from the mean, individual 
subjects' scores were investigated. Qualitative analysis of the 
interviews provided deeper insights into the subjective experience 
of the subjects. 
Chapter three 
RES U L T S • • 
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The interplay between MS, depression, anxiety, and fatigue on 
cognition is complex. The subjects, volunteering on the basis that 
they had cognitive deficits due to MS, were beset with doubt . Many 
expressed a 'need to know' whether or not their self-perceived 
cognitive symptoms were objectively there, and whether or not they 
could confidently attribute them to MS. 
3.1. THE NEUROPSYCHIATRIC INTERVIEW 
3.1.1. Uncertainty 
"I still doubt myself. 
legitimate and I'm not 
need to know if others 
I need to know it's 
just playing games. I 
are feeling this way ." 
Subjects identified many reasons for their uncertainty, but often 
struggled to express themselves. Many used unique metaphors: 
"there's a space between me and. the meaning of the word"; "a 
sluggishness of thinking. There isn't crispness"; "I have to scrub 
my brain to get it to work properly"; "it feels muddy"; "my mind 
feels like a train with squeaky wheels". 
"I can't help thinking what connection it 
has with Alzheimer's, and then I think, 
'Don't be ridiculous' . " 
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The concept of MS-caused cogni ti ve symptoms was upsetting and 
threatening; "Not walking is one thing. But cognition! ... [It's] 
too horrific!" . Many actively avoided confronting their self-
perceived cognitive deficits. Those who worked at home tended to 
be in non-intellectually demanding employment, and admitted that 
this made them feel safe: "I've always used my brain. Now as a 
housewife I'm not being tested; [it's] tucked away enough that it 
won't be revealed". One woman had left two jobs because she "felt 
[she] was letting the company down because [she] was forgetting 
things ... would have caused the company a lot of embarrassment". 
One subject abandoned her masters research owing to anxiety that 
she could no longer "make it" . Another refrained from starting her 
own company because it meant people would then rely on her. They 
could understand that employers lost trust in them and they lost 
trust in themselves. 
This lack of trust and self-doubt was exacerbated by the disbelief 
of relatives or medical practitioners, making them feel they were 
"frauds" and "neurotic". While all had been told of the 
possibility of paralysis, none had been told of the possibility of 
cognitive symptoms. Even those who had directly asked had been 
told "not to worry", and MS "only affected the white matter so it 
couldn't cause intellectual problems". 
Those that complained of cognitive symptoms had usually been told 
it was depression or stress . Problems they associated with 
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cognitive difficulties were easily attributed to · "laziness" or 
"manipulation" , or being "maIn [mad] , causing family and 
occupational strife . Many of the subjects had experiences of 
vehemently denying conversations or decisions they had made, only 
to be proved wrong. In turn, this led to feelings of humiliation, 
shame, vulnerability, lack of confidence, and "feeling stupid". 
Uncertainty resulted in a tendency to dismiss or laugh off the 
symptoms as "quaint". Many felt they avoided dealing with the 
threat by "covering up" their mistakes (with witticisms, humour, 
down-playing etc.). One felt he not only convinced others there 
was nothing wrong, but sometimes "fooled" himself into thinking 
there was nothing to worry about. 
3.1.2. Confirmation 
"I began to read about cognitive symptoms in [MS] 
newsletters . I felt triumphant, like 'I told you 
so!' I felt like going to the medical doctors and 
shoving it under their noses, to say 'You see? I 
was right! It wasn't in my mind!" 
All subjects had found out about the possibility of MS causing 
cogni tive symptoms through multiple sclerosis societies, self-
education, or talking to other people with MS. In many cases, 
subjects believed it was merely confirmation of an idea "already 
realized". For many it was "comforting" and "reassuring" to know 
that they had not "made things up" or were not accountable for 
certain behaviours and decisions. Along with the relief were 
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feelings of sadness; "it was another thing the illness was taking 
away" . All expressed fear at their experienced and anticipated 
potential cognitive losses, and although they wanted it "to be 
proved", they felt they "desperately did not want it to be true". 
All subjects believed that MS could cause cognitive deficits as all 
had at times experienced MS-caused cognitive deficits, with eight 
of the ten believing their memory had been affected. 
"I forget I've got something in the oven. 
Even if I'm standing next to the stove, 
I can't understand what's burning." 
Other volunteered examples were: loosing track in conversations; 
inability to maintain concentration when reading; feeling "unable 
to understand"; being "muddled"; "confused" and "slow"; feeling 
disinhibi ted; having a "short fuse"; becoming "easily upset and 
angry" . Several factors were associated with these symptoms 
becoming more severe: fatigue; MS exacerbations; worry; stress; 
extremes of temperature; and being confronted with complex 
material . 
Subjects employed several "tricks" to help themselves. Most were 
avid list-keepers, kept diaries, checked and re-checked work, aided 
their memory through means of association and repetition, and 
depended on friends and family to remind them. 
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3.2. SCREENING MEASURES 
The screening measures were also used for analysis. (See Table 3 . ) 
Subjects performed normally on the MMSE, showing no or minimal 
signs of cognitive decline . Subjects scored Iowan the HRS, and 
had few (if any) clinical signs of depression. 
Table 3 
SCREENING MEASURES: 
Test 
MMSE 
(N=10) 
HRS (score doubled) 
(N=10) 
Mean 
28.3 
14.2 
3.2. PSYCHO-SOCIAL INDICES 
Std Dev 
1.252 
6.215 
Range Maximum 
26 - 30 30 
6 - 26 102 
Formal indices of major depression (on the HRS and the MCMI-MDE) 
were low. The GHQ indices were insignificant and non-contributary . 
In contrast, the MCMI-II scores were elevated for both anxiety and 
dysthymia . (See Table 4.) Eight subjects had elevated scores 
(over 75) for dysthymia, and six for anxiety. The mean score was 
above 75 for both the Dysthymia and Anxiety scales. When the one 
outlier score was removed, the means rose dramatically. 
Individual and familial histories revealed a marked degree of 
psychiatric distress and treatment. (See Table 5.) All the 
subjects had, in the past, either considered suicide, or considered 
themselves "seriously depressed", and seven subjects had sought 
professional help for depression. More than half the subjects 
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described themselves as currently depressed or were taking anti-
depressant medication. Atypically, more than half the subj ects had 
family histories of suicide (N=4), alcoholism or depression. 
Table 4 
TESTS OF PSYCHOLOGICAL WELL-BEING: 
Test Mean Std Dev Range Maximum 
GHQ 5.1 5.195 o - 17 28 
(N=10) 
GHQ-Anxiety 1.0 1 . 155 o - 3 7 
(N=10) 
GHQ-Social Dysfunction 1.5 1.900 o - 6 7 
(N=10) 
GHQ-Somatic Complaints 2.0 2.357 o - 7 7 
(N=10) 
GHQ-Depression 0.6 0.843 o - 2 7 
(N=10) 
MCMI-II : MDE 61.9 7 . 737 47 - 76 
(N= 9) 
MCMI-II Dysthymia 79.0 28.236 5 - 97 
(N= 9 ) 
* MCMI-II Dysthymia 88.3 5.574 77- 97 
(N= 8) 
MCMI-II Anxiety 75.6 28 . 784 5 - 105 
(N= 9) 
* MCMI-II Anxiety 84.4 12.118 68 - 105 
(N= 8) 
One subject did not complete the MCMI-II. 
(11*" indicates the removal of the outlier score. ) 
Subjects experienced significant chronic stress related to their 
MS. Many were anxious that either continued forgetfulness would 
resul t in their being fired, or not being promoted. Others 
mentioned continued financial and familial/marital difficulties. 
In addition, subjects described being "wiped out" by the "continual 
humiliation" and disability resulting from symptoms (e.g., 
incontinence) . 
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Half the subjects experienced significant stressful events during 
this research: one subject, when at home, had "watched herself" 
raise a loaded gun to her head, feeling it was not herself; in one, 
a confirmation of pregnancy; there were two marital separations; 
one person's child diagnosed with Tourette' s Syndrome; and one 
subj ect had a MS exacerbation. A few subj ects attended the 
assessments, knowing their families / doctors disapproved. In one 
case, a family member was actively resistant to the research, 
claiming that "it was nonsense" and that any "quirks" had been 
there "before [onset of MS]". Conversely, other family members 
were delighted and felt their "instinct" that something was wrong, 
was confirmed. 
Table 5 
OTHER INDICES OF MENTAL STATUS: 
Subjects who have considered suicide in the past, 
or considered themselves seriously depressed: 
Subjects who have in the past, received 
professional help for depression: 
Subjects on anti-depressants or who feel 
depressed: 
Subjects who currently describe themselves as 
depressed: 
Subjects currently on anti-depressants or 
benzodiazapines: 
Subjects with depression, suicide or alcoholism 
amongst immediate family members: 
Subjects where an immediate family member has 
committed suicide (including grandparents and 
first cousins): 
(N=10) 
10 
7 
7 
5 
5 
6 
4 
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3.3. CLINICAL OBSERVATIONS 
Many subjects found the assessment process stressful and felt they 
"had to impress" the examiner with their intelligence. In 
neuropsychological tests where difficulties were encountered, some 
subjects felt humiliated and ashamed. One subject wept when unable 
to perform at a level she had anticipated she should be able to. 
Despite constant reminders, three subjects forgot appointments. 
Throughout the clinical interviews, subjects commonly lost track of 
the conversation (e. g., "What was I going to say? What on earth was 
it!"). 
3.4. NEUROPSYCHOLOGICAL TEST RESULTS 
Cognitive deficits were confirmed by neuropsychological test 
results . Performances varied noticeably between subjects. 
3.4.1. Intelligence 
The mean Full Scale Intelligence Quotient (FSIQ) was within the 
superior range. Four subjects scored in the superior range, four 
in the high average range, and one in the average range of general 
intelligence. 
(See Table 6.) 
On average, VIQ was nine points higher than PIQ. 
Subtest score means were lowest for Obj ect 
Assembly, Digit Symbol and Arithmetic . However, mean subtest 
scores were never below the mean for the general population. 
Subjects performed best on Similarities, Picture Completion, Digit 
Repetition, Comprehension and Picture Arrangement. 
t 
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Tabl~ 6 SAWAIS Resylt!l (N=2l 
SAWAIS TEST MEAN STD DEV RANGE 
FSIQ 121.889 10.729 108.0 - 143.0 
VIQ 126.222 10.485 116.0 - 148.0 
PIQ 117.333 13.426 91.0 - 138.0 
SAWAIS Subtests Mean Std Dev Range 
Information 11.111 1.193 8.5 - 12.0 
Comprehension 13.111 3.140 9.0 - 18.5 
Arithmetic 10.556 1.590 8.0 - 13.0 
Digit Repetition 13.444 1.357 11.0 - 15.5 
Similarities 15 . 111 1. 516 13.0 - 18.0 
Picture Completion 13.556 1.776 10.0 - 15.0 
Object Assembly 10.333 2 . 000 7.0 - 14.0 
Block Design 11.278 1.622 10 . 0 - 15.0 
Digit Symbol 10.500 2.236 6.5 - 13.0 
Picture Arrangement 13.111 1.816 10.5 - 15.5 
3.4.3. Tests of Attention 
The means for both TMT-A and TMT-B were below the 50th percentile. 
(See Table 7.) Eight subj ects scored at or below the 30th 
percentile and the two other subjects scored at the 63rd and 78th 
percentiles, respectively. Of note, subjects performed better on 
TMT-B . Only four subjects performed below the 30th percentile, and 
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four scored above the 50th. The highest percentile score for TMT-B 
was at the 88th percentile. In contrast, performance on DF 
(SAWAIS) was superior and relatively consistent for all subjects. 
Subjects also performed above average on VMS (WMS-R), which was 
commensurate with their performance on Digits Forward (SAWAIS). 
Table 7. Tests of Attention (N=10) 
Test Mean Std Dev Range Mean Percentile 
TMT-A (in seconds) : 50.7 20.3 25 - 82 26th 
TMT-B (in seconds): 98.8 53.3 46 - 219 41st 
DF (SAWAIS) : 7.889 0.78 7 - 9 
VDF (VMS, WMS-R) : 5.7 0.483 5 - 6 83rd 
3.4.5. Tests of Learning and Memory 
Prospective memory was impaired in most subjects (N=8). (See Table 
8.) Four subjects failed to remember any tasks, and only two were 
able to recall all three. On the episodic memory questions, 
subjects tended to perform better, but often relied on customary 
routines to do so; "I always have a slice of toast for breakfast". 
Many coinplained of "going blank". 
On tests of working memory, the mean performance on auditory tasks 
{i.e., Serial Sevens, DB (SAWA1S)} was superior to the mean of 
visual working memory tasks (VDB (WMS-R), TMT-B). On Serial 
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Sevens, all the subjects scored four or five out of five. The mean 
score on DB (SAWAIS) was 6.1, which was well above average. 
However, on VDB (WMS-R) the percentile performace dropped to the 
68th percentile. As mentioned, on TMT-B, almost half the subjects 
scored below the 30th percentile. 
Subjects performed poorly on the RVALT, with subjects scoring a 
mean of 5.8 words for Trial 1. Eight subjects failed to score 
above the 50th percentile on any of the five trials. The other two 
subjects consistently scored at the 70th to 80th percentile range. 
All but one subject displayed a learning curve over the five trials 
on RAVLT, and on average had learned five extra words by their 
fifth trial. As expected, recognition memory was preserved, with 
almost all (N=8) correctly identifying 14 or 15 target words. 
There was minimal forgetting on delayed recall, with subj ects 
forgetting, on average, only one word. There were few examples of 
confabulations and repetitions in the list learning. 
On Logical Memory, the mean was below the 50th percentile. 
Nonetheless, compared to the RAVLT, subjects performed better on 
this task where the story ' s logic could aid memory recall. Only 
one subject scored below the 40th percentile, and almost half above 
the 50th percentile. On delayed recall, there was a slight drop in 
performance, with subj ects, on average, forgetting one word or 
concept. 
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There was a wide range of performance for auditory new learning. 
Almost half the group learned the Digit Supraspan within two to 
three trials. One person was unable to learn the DSS despite ten 
attempts, although this subject was able to learn the VSS. 
Three subjects were unable to learn the HBVR visuospatial pattern 
(N=9). However, as with RAVLT, subjects did well on recognition 
(as expected), and delayed memory tasks. All of the subjects 
scored the maximum on visual recognition (i.e., nine out of nine), 
and displayed minimal deterioration wi th delayed memory tasks. Two 
subjects were unable to learn a visual supraspan (N=lO). 
With complex visual memory (e.g., ROeF), scores were significantly 
below normal. Although the subjects demonstrated excellent 
visuographic copying skills on the ROeF, the mean percentile for 
ROeF memory was low at the 26th percentile. 
On Digit Symbol Incidental Recall (SAWAIS), performance varied 
markedly. Subjects' recall ranged from two to nine symbols. The 
mean (six out of nine) was below the norm . 
Table 8. Tests of Memory 
Test Mean 
Prospective Memory: 1.4 
Episodic Memory: 2.9 
Std Dev 
1.265 
.876 
Range 
0-3 
1 - 4 
Maximum 
3 
4 
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Te§t§ Qf WQrking M~Qr;:y {N=lOl 
Test Mean Std Dev Range Mean Percentile 
Serial Sevens: 4.6 .5 4 - 5 
Digits Backward: 6.111 0 . 928 4 - 7 
VDB (WMS-R) : 4.5 0.527 4 - 5 68th 
TMT-B (in seconds): 98.8 53.3 46 - 219 41st 
Te§ts Qf Auditory Memor;:y {N=lOl 
Test Mean Std Dev Range Mean Percentile 
Rey Auditory Verbal Learning Task 
Trial 1: 5 . 8 2.530 1 - 9 34th 
Trial 2: 8.0 2 . 449 4 - 13 33rd 
Trial 3 : 9 . 5 2.877 4 - 14 27th 
Trial 4 : 10 . 2 2.201 8 - 14 21st 
Trial 5 : 10.7 2.359 6 - 14 27th 
List B: 5.9 1.197 4 - 8 31st 
Recognition, +ve: 13.6 1.897 9 - 15 
Recognition, -ve: 0 . 7 1.059 0 - 3 
Trials 5 minus 1: 4.9 1. 969 1 - 9 
Repetitions: 2 . 7 3.529 0 - 11 
Confabulations: 1.2 1. 687 0 - 5 
Delayed recall : 9.1 2.767 5 - 13 
Logical Memory Mean Percentile 
lnunediate: 12.6 4.526 6 - 22 48th 
Delayed: 11.7 4. 373 5 - 20 45th 
SAWAIS 
Digi t Supraspan : 4 . 556 2 .297 2 - 9 
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Tests of Visual Memory 
Test Mean Std Dev Range Mean Percentile 
Visual Digit Span (WMS-R) (N=lO) 
VSS: 7.3 2.627 4 - 11 
HBVR (N=9) 
Trials to learn: 6.6 3.539 2 - 11 
Total Errors: 11. 6 15.241 0 - 45 
Recognition: 9. 0.000 9 - 9 
Delayed: 7.8 1. 093 6 - 9 
RoeF (N=10) 
Copy: 35.2 1.229 33 - 36 90th 
Memory: 17 . 5 4.620 12 - 25 26th 
SAWAIS (N=9) 
DSIR: 6. 2.345 2 - 9 
3.4.4. Tests of Language 
Despite adjustments for age, sex and years of education, the mean 
percentile performance (55th percentile) on COWAT was significantly 
less than expected, given the mean general intellectual performance 
of the subjects. (See Table 9.) As with the general population 
(Lezak, 1983), mean performance was better on the semantic cues 
over two categories, when compared to phonemic cues. All the 
subj ects responded promptly and accurately on the Renfrew Word 
Naming Test. 
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Table 9 . Tests of Language (N=10) 
Test Mean Std Dev Range Mean Percentile 
Re nfrew : 57.4 1.506 54 - 59 
CFL / minute: 41. 6 10.71 23 - 57 55th 
Semantic: 17.3 5.539 8 - 25 
3.4.6 . Tests of Abstract / Reasoning Ability 
On the WCST, eight subjects were able to predict sequences within 
three trials, while two failed to. (See Table 10.) More than half 
the subjects (N=6) were able to predict the first criterion within 
13 attempts (the norm) (Heaton, 1981) . However, the mean error 
score was elevated by the other subjects who struggled to predict 
the sorting category. By the second trial, three subjects were 
able to shift the set within five attempts, and by the last trial, 
eight were able to predict the new sequence within five attempts. 
However, the mean rose for the last trial, as the other two 
subjects were unable to predict the pattern, and scored the maximum 
of 50 errors. One subject became angry and accused the examiner of 
"unfairly" changing the pattern " every time". On Similarities 
(SAWAIS), subjects performed significantly above the mean for the 
general population . 
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Table 10. Tests of Abstract I Reasoning Ability 
Test Mean Std Dev Range 
WCST: (Number of errors) (N=lO) 
Trial 1 : 15.1 l5.30B 3 - 50 
Trial 2: B.3 7.0BB 2 - 25 
Trial 3 : 12.1 19.991 2 - 50 
SAWAIS (N=9) 
Similarities: 15.1 1.516 13 - 1B 
3.4.2. Tests of Handmotor Dexterity 
Most of the subjects struggled on the GPT, and some were unable to 
feel or manipulate the grooved pegs . For each hand, every subject 
scored beneath the 50th percentile, and eight scored below the 
first percentile. (See Table 11.) No subject took more than five 
minutes to complete the board. 
Table 11. T!i!!J:t!J Q~ HandmQtQr D!i!;!!;:t!i!ri:ty (N=lO) 
Test Mean Std Dev Range Mean Percentile 
Grooved Pegboard (in seconds) 
Right Hand: 10B.B 33.529 60 - 161 Bth 
Left Hand: 146.7 66.622 73 - 265 7th 
3.5. MRI RESULTS 
Of the ten subj ects, eight underwent MRI investigations. (See 
Table 12.) One pregnant subject was excluded on the advice of the 
Chief Radiographer and another left the study before her MRI was 
done. 
Table 12. MRI Results (in millimetresl (N=81 
Dimension Mean Std Dev Range 
Total Diameter 181. 717 94.047 51.28 - 350 . 48 
Right Diameter 97.984 44.529 35.90 - 156.19 
Left Diameter 83 . 733 59 . 565 11.91 - 196.19 
Total No . Lesions 35.125 16 . 505 7 - 57 
Right No. Lesions 19.875 10.092 5 - 37 
Left No. of LesNs 15.250 8.746 2 - 27 
Site of corpus callosal atrophy: No atrophy: 4 
Anterior: 2 
Posterior: 1 
Whole of CC: 1 
Degree of callosal atrophy : None : 4 
Mild : 3 
Severe: 1 
Ventricular dilatation: None: 3 
Mild to moderate: 2 
Moderate: 1 
Moderate to severe: 1 
Severe: 1 
Brain Stem Lesions: Yes: 2 No: 6 
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Half the subj ects who underwent MRl scans had minimal or no 
evidence of corpus callosal atrophy or ventricular dilatation . The 
number of lesions per subjects varied markedly (from seven to 57), 
and on average, there were more lesions visible in the right 
hemisphere. 
Six subjects made earlier MRl scans available to the 
neuroradiologist . Although not specifically looked-for, the 
"waxing-waning" nature was evident, when compared to earlier MRl 
scans. For three subjects, ther e were decreases in the number of 
lesions and total summed diameter of plaques, or less atrophy 
apparent . 
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Chapter Four 
DISCUSSION AND CONCLUSION 
4.1. INTRODUCTION 
Multiple sclerosis is a disease beset with problematic diagnoses, 
unpredictable prognoses, and "invisible" symptoms (Thornton & Lea, . 
1992). Most cognitive symptoms tend to be experienced 
subjectively, and are often not recognized by other people. 
Typically, psychological reactions may be to exacerbate or deny 
these symptoms (Harrower, 1987; McDonald & Silberberg, 1986). 
This research was primarily concerned with the subjective 
experience of cognitive difficulties in people with MS. Subjects 
struggled to legitimize their experience of cognitive deficits to 
themselves and to others. With few exceptions, subjects 
experienced chronic stressful circumstances, both related and 
unrelated to their cognitive difficulties. On tests of mental 
state screening measures and general intelligence, there was no 
evidence of cognitive deterioration. However, on sophisticated 
neuropsychological testing, there was convincing evidence of 
cognitive problems, commensurate with a subcortical dementia. 
Lesions on MRI were not typical of the reported incidence of 
ventricular dilatation and corpus callosal atrophy in MS patients 
with cognitive deficits. 
l_ 
\ 
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4.2. SUBJECTIVE EXPERIENCE: ANXIETY AND uNCERTAINTY 
The most striking feature of this research was the pervasive and 
elevated levels of anxiety and insecurity experienced by the 
subjects. 
"forgetting" 
This anxiety was expressed 
appointments, to high 
in many 
scores 
ways, from 
on anxiety 
questionnaires, to breaking down during testing sessions, and the 
articulation of fears and self-doubt. 
The debate between "is it real?" or "is it imagined?" was stressful 
as subj ects struggled to come to terms with subtle cogni ti ve 
symptoms. In some subjects, the fact that their cognitive symptoms 
would "come and go", heightened their lack of confidence . Often MS 
patients feel " frauds", and the need to know or confirm that what 
they exper ience is not imagined, can be compelling. 
contributed to feelings of inadequacy and dysthymia . 
This also 
A neuropsychological assessment of this nature places enormous 
demands on the person being tested, and one cannot underestimate 
the stress involved for a person who may dread the outcome. When 
subjects " forgot" appointments, it was difficult to establish 
whether this · was due to anxiety or forgetfulness. For the 
subjects, the" choice was either "proof" of cognitive deterioration 
(and the fantasies of dementia), or evidence that they were 
" emotional" or neurotic, and "making it all up". Despite the fears 
of dementia, most preferred that their subjective experience of 
cognitive deficits would be validated by the assessment . 
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4.3. INTELLIGENCE AND EDUCATION 
The second striking feature about this research, was the superior 
mean intelligence of the subjects. In all other studies known to 
this researcher, the FSIQ, VIQ and PIQ were reported as average 
(Izquierdo et al., 1991; C. G. Mathews et al., 1970; McIntosh-
Michaelis et al . , 1991; Rao et al., 1991a), while, in this group, 
the FSIQ and VIQ were superior, and the PIQ high average . 
As the subjects were volunteers there were limits to the number of 
variables that could be controlled. The mean number of years of 
formal education was also higher than in other studies. Further, 
an age limit may also have had an influence on the high mean 
intelligence. 
It is possible that people who invest in their intelligence as a 
primary important self-identity are more likely to be threatened 
by, and be conscious of, cognitive changes. A resultant 
"hypersensitivity" to cognitive changes, experienced or imagined, 
may thus occur more readily in subjects with superior intellectual 
functioning . 
may be more 
People with higher investment in their intelligence 
likely to fear cognitive deterioration. Further , 
people who are more worried about the occurrence of cognitive 
deterioration, may be more willing to volunteer for related 
research. 
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4.4. RESULTS: NEUROPSYCHOLOGICAL TESTS 
In such highly educated and younger subj ects, scores in the 
"average" range, represent decline in cognitive performance. Mean 
percentile scores below the 89th percentile (the mean intellectual 
functioning performance) must thus be explained. 
Despi te the differences in the mean intellectual performances, 
distributions on the SAWAIS concurred with other research. On 
average, PIQ is 7-14 points less than VIQ, Digit Symbol is the 
lowest, and Picture Completion the highest PIQ score (Rao, 1986). 
This study replicated these findings, and confirmed that the 
subjects experienced neuropsychological deficits. 
Many MS patients have impaired sensory (e.g. , numbness, 
proprioceptive loss) and fine motor functioning. Thus, people with 
MS tend to perform poorly on tests of motor dexterity and tests 
sensitive to deficits in speed and capacity of processing (Grigsby 
et al., 1994), such as the GPT, TMT and Digit Symbol (SAWAIS). On 
the GPT and TMT, subj ects' mean performance was significantly 
slower when compared with MS patients in Klonoff et al. (1991). 
However, performance was superior, when compared to C. G. Mathews 
et al. (1970). 
There was some evidence of 1ateralization of function on tasks of 
attention {DF (SAWAIS) and VDF (WMS-R)}, and working memory {DB 
(SAWAIS) and VDB (WMS-R)}. Subjects' mean performance was two 
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digits longer on the auditory tasks, when compared to the visual 
equivalents. In addition, subjects performed poorly on the ROeF, 
acomplex visual memory task. Together, these raise the possibility 
of right hemisphere involvement. However, further examination of 
the auditory memory test profile suggested contrlateral pathology. 
There were substantial impairments evident in both prospective and 
episodic memory. Many subj ects appreciated these impairments to be 
"exactly what happens all the time!", contributing to situations of 
embarrassment and humiliation. Some subjects expressed relief to 
be able to confirm for themselves, that they had these 
difficulties, and that their memory problems were identifiable by 
a name (e.g., "prospective memory"). 
On multitrial learning tasks, the average performance of MS 
patients is usually impaired on the first trial, implying some 
aspect of encoding is impaired. Thereafter, learning proceeds at 
a normal rate, and the proportion of material retained after a 
delay within normal limits (Minden et al., 1990b; Beatty, 1993). 
Again, on the RAVLT and HBVR, this research replicated these 
findings, including relatively preserved delayed memory and 
recognition skills. 
Normally, Digits Forward (DR, SAWAIS) and the number of words 
recalled on RAVLT Trial I should be within one or two points of 
each other (Lezak, 1983). However, patients with intact immediate 
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memory who become confused by too _ much stimulation tend to show 
larger differences (favouring DF). Lezak (1983) -found such 
patients to have difficulty with complex material (or situations of 
any kind), but found them to do better on simplified, highly 
structured tasks. The poorer relative performance of RVALT Trial 
I recall when compared to the DF (DR, SAWAIS), was probably in due 
to information overload. 
Compared to RAVLT, there were relatively better accomplishments on 
passage recall (Logical Memory), although performance was still 
impaired. Possibly, the story's logic acted as a cue, assisting 
subjects' memory. 
On tasks of verbal fluency, MS patients are consistently impaired 
Beatty, 1993). Although the mean percentile for the subjects was 
above the 50th percentile, it was lower than expected for people 
with their obvious intellectual potential. 
Abstract thinking is frequently reported as impaired in the MS 
literature on cognition (Rao, 1993). However, in this study, 
performance on Similiarities (SAWAIS) and WCST, a test of executive 
function, was intact. 
4.5. THE MRI 
Half of the people undergoing MRI investigations had no corpus 
callosal (CC) atrophy, and no or minimal ventricular dilatation. 
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The mean accumulative diameter across all the plaques was less than 
20cm. This is atypical of many MRI studies examining MS and 
cognition, where CC atrophy, ventricular dilatation, and a total 
plaque diameter in excess of 20 to 30cm is usually described in 
patients suffering cognitive deficits. 
While postmortem studies have shown MS lesions to be distributed 
evenly across both hemispheres (Rao, Hammeke, McQuillen, Khatri & 
Lloyed, 1984), this research evidenced a greater mean total number 
of lesions (TNL) in the right hemisphere. This may be explained by 
a the small sample size, and thus Type II error. Nonetheless, the 
greater number of lesions in the right hemisphere found in this 
research is of interest, given the lateralized results in attention 
and working memory tasks. 
The clinical significance of such lesions however, remains 
controversial (Comi et al., 1993; Smith et al., 1993). Even if 
patients have virtually identical MRI results, a marked variability 
in cognitive test performance may occur (Feinstein, Ron & Thompson, 
1993). Silent lesions (lesions without corresponding symptoms) 
(Warren, Warren & Cockerill, 1991) are common on MRI, and new 
lesions can occur at approximately ten times the frequency of new 
clinical episodes (Rao, 1990). In addition, detectable 
abnormalities could represent lesions in different stages of 
evolution (Ron et al., 1991). 
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Multiple sclerosis lesions are not static. Some subjects had few 
lesions at the time of testing, compared to previous MRI scans. It 
would be necessary to match the waxing / waning nature of the 
number and position of the lesions, against performance on 
neuropsychological testing, in order that the effect of lesions can 
be clearly defined. The waxing and waning nature of the lesions 
imply that cognitive deficits in MS may fluctuate. This 
possibility is supported by the subjects' accounts of their 
personal experiences. 
4.6. THE NEED TO ACKNOWLEDGE 
While cognitive impairment in MS patients as a fact of illness is 
accepted within the neuropsychological community, this cannot be 
said of the neurological community at large (Rao, 1990). Despite 
the fact that for over a century it has been recognized that 
affective and cognitive symptoms are prevalent in mUltiple 
sclerosis, cognitive symptoms in MS have been largely ignored or 
denied. Subjects who did suffer from memory and concentration 
difficulties were often told it was due to other problems, mostly 
"stress", and that it was not caused by MS. This can lead to 
feelings of distrust - with MS patients feeling that medical 
professionals are withholding information (Thornton & Lea, 1992), 
and with professionals fearing that they have to treat "yet another 
hysterical" patient. This is not to deny that at times, a patient 
may present with a psuedodementia. 
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Part of the reason for the lack of acknowledgment, is that many 
neurologists themselves are ignorant of the possible cognitive 
consequences brought about by MS . Further, with contradictions and 
overestimations of cognitive deficits being frequently published, 
medical practitioners may be skeptical of the literature. A 
balance between unnecessary alarm and realistic response must be 
reached (Rao, 1990). 
Of all a human's faculties, probably intellectual capacity is the 
most valued (Rao, 1990). Together with sexual dysfunction 
difficulties, many medical practitioners are uncomfortable in 
imparting such potentially devastating news (Ron & Feinstein, 1992) 
- especially when the aetiology of the symptoms remains so unclear. 
In addition, unlike physical symptoms, cognitive impairment does 
not respond to short courses of corticosteroids (Rao et al., 1993), 
leaving the medical practioner helpless to assist the patient . 
It has been shown that clinical neurologists will miss significant 
cogni tive dysfunction in up to half the patients they examine 
(Beatty & Goodkin, 1990b). Mild cognitive impairment can easily go 
undetected . Cognitive deficits, even for neurologists sensitive to 
the issues, are often difficult to recognize in patients with MS 
(Rao et al . , 1993). Brief standardized mental status examinations 
(e.g., the MMSE) and standard clinical neurological examinations 
may be insensitive even to moderate cognitive impairment (Peyser et 
al., 1990; Prosiegel & Michael, 1993). From this research, it is 
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evident that even MS patients with minimal or no corpus callosal 
atrophy, no ventricular dilatation, relatively few lesions and a 
low accumulative plaque diameter, still have cognitive deficits . 
Even if neurologists who treat MS patients suspect cognitive 
deficits, they may hesitate to refer the patient for additional 
neuropsychological testing, given the considerable cost and time 
required for a truly thorough examination of cognitive capacity. 
As a simple rule of thumb, Beatty and Goodkin (1990b) recommend 
that any MS patient (especially those with a high school education, 
and without severe disability) who score below the norm on the 
MMSE, require additional neuropsychological evaluation. 
It is important that cognitive difficulties be recognized as common 
symptoms in MS, as recognition can lead to acknowledgement and 
treatment. Confirmation (of a chronic illness or a symptom within 
it) can lead to relief and comfort. It legitimizes the person's 
experiences and needs. Understanding what is happening minimizes 
the stress related to "not knowing", and can empower the patient 
wi th knowledge and acceptance. This not only occurs with the 
initial diagnosis of physical symptoms (which for many patients 
follows a traumatic period of not only "not knowing", and not being 
believed), but also with the experience of cognitive deficits. 
Often it is possible that the person can learn to compensate for 
their impai rments. 
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4.7. COGNITIVE RETRAINING AND PSYCHOSOCIAL INTERVENTION 
While there has been extensive research into the cognitive 
functioning of people with MS, as yet there has been minimal 
research into cognitive retraining. However, the field of 
neuropsychology is currently shifting from mere diagnosis per se 
towards more description, explanation and rehabilitation (R. 
Taylor, 1990). 
Many patients with MS have a benign course and are suitable for 
long-term neuropsychological treatment (Prosiegel & Michael, 1993). 
Remediation (partial or complete restoration of impaired function 
via therapy, e.g., speech therapy), adaption (with external aids), 
and compensation and accommodation (via residual or undisturbed 
functions) are all imperative. Restorative techniques, targeted at 
specific cognitive tasks, (Rao et al., 1993) have enjoyed 
particular success. Recently, computer-assisted memory remediation 
programmes and pharmacological manipulation (Peyser et al., 1990) 
have been applied in cognitive retraining programmes. 
More simply, keeping diaries, displaying large month-planners, and 
cautioning family members to remind, are effective ways of dealing 
with the more mild and commonly experienced memory difficulties. 
Not surprisingly, all the people in this research had instinctively 
turned to some form of self-help compensation. 
Because of the heterogeneity of the illness, programmes need to 
cons ider individual needs. 
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Despi te the differing psychosocial 
experiences, MS patients experiencing cognitive symptoms are all 
eligible recipients for a counselling programme which deals with 
grief work, self-image, and anxiety management. Even if the 
patient mistakenly believes they suffer such cognitive deficits, 
then a programme of counselling around these issues remains 
necessary. It may be that in cases of pseudodementia, the 
underlying causes can be remedied and the cognitive deficits 
reversed. 
This research demonstrates the fundamental importance of assessing 
anxiety and depression in MS patients presenting with cognitive 
symptoms. Therefore, any efforts at cogni ti ve retraining and 
psychosocial intervention should as a matter of course, include 
stress management and examination of the factors causing the 
anxiety. Counselling targeted at improving self-image and 
recognizing the symbolic and functional importance of cognitive 
abilities can relieve much of the associated stress. 
4.8. ESTABLISHING AN AETIOLOGY 
Neuropsychiatric dysfunction in people who have multiple sclerosis 
can be independent of, and merely coincidental to MS; or 
predominantly reactive to the stresses inherent in the illness; or 
directly related to the lesions of the disease (Honer et al., 
1987). In addition, when MS patients are on medication, the 
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pharmacological influences on test performance must be accounted 
for. In this study, a pharmacologist carefully assessed the 
influences of each subject's medication on neuropsychological test 
performance . It is considered the sample is "relatively 
uncontaminated by medicines" (Dr A. Robbins, personal 
communication, March 8, 1995) . 
This research highlights the difficulty of unravelling the 
aetio10gical factors of cognitive dysfunction, with more than half 
the sample having familial and individual psychiatric histories, 
almost half the sample having an unrelated (to MS) cerebral assault 
(e.g., pulmonary embolism), and many experiencing significant 
stressful life events (e. g., two marital separations) . One subj ect 
had a relapse, where typically the subjective response to a 
deterioration in physical well-being can lead to considerable 
stress and depression (Feinstein et al . , 1993). And in turn, the 
above factors may influence psychometric test results . It is 
imperative that a thorough familial and indi vidual history be 
conducted, and psychological well-being be assessed, in any 
research into cognitive functioning in MS . 
Ron et al . (1991, p . 66) who, on interview , found 25 / 58 of the MS 
subj ects to be psychiatric "cases" , concluded that psychiatric 
symptoms and the cognitive deficits represented two "intricately 
linked" parameters. It 
isolating confounding 
is easy to appreciate the difficulty of 
variables and the extremely complex 
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relationship between them. The interaction of the organic, 
pharmacological, psychological, psychiatric and social factors are 
crucial to developing a model to explain the pathogenesis of 
cognitive and psychological changes in MS. It is only a 
multifactorial aetiology, that can make better sense and explain 
cognitive dysfunction in multiple sclerosis. 
A plaintive cry, ending most researchers' conclusions on cognitive 
research in MS, is the call for longitudinal studies . It was the 
intention from the outset of this research, that the ten subjects 
be involved in a five-yearly follow-up. In this way, causal 
inferences (of necessity, limited in cross-sectional studies) can 
be made, and a clearer understanding of the interplay between 
cognitive and psychological paradigms, be obtained. 
4.9. CONCLUSION 
Psychiatric and cognitive symptoms can occur both in the early and 
in a later stage of the disease, and they cause much despair . 
Research (Ron & Feinstein, 1992) has shown that cognitively 
impaired MS patients experience more significant difficulties in 
work, social contact, sex and activities of daily living, than 
those without. In addition, MS patients with cognitive disability 
are less likely to receive disability benefits (or receive them 
later) than their physically disabled counterparts (Rao et al., 
1991b). 
I 
\ 
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Difficulties in memory, concentration, self-control and emotional 
expression can lead to feelings of guilt, misunderstanding, anger 
and rejection. Failure to recognize cognitive impairment can lead 
to unrealistic expectations and difficulties in family members' 
adjusting to a patients's disease. Without accurate information, 
relatives of cognitively impaired MS patients tend to attribute 
their problems to elective obstinacy, depression, or other forms of 
disturbance (Rao et al., 1991b) . Lack of understanding may 
aggravate the stressful situation for the patient and the family. 
"Feeling of knowing" (Beatty & Monson, 1991), is a term used to 
assess to what degree research participants can predict their own 
performance. It shows that subjective cognitive impairment 
reflected on neuropsychological testing is often related to 
functional impairment. More than that, the patient is "being taken 
seriously", and an acknowledgement that cognitive deficits may be 
"unseen", but nonetheless lead to disability. Therapy allows the 
patient and family to recognize and accept cognitive loss, and 
bestows understanding of the deteriorative nature of the disease. 
All psychological and cognitive symptoms, whether organi c or 
"emotional", need to be taken seriously, ' with regular referrals for 
neuropsychological assessment. Acknowledgement is a first, but 
vital step in ensuring fulfilled and dignified lives for people 
suffering from cognitive deficits. 
4.10. LIMITATIONS AND SUGGESTIONS FOR FUTURE RESEARCH 
4.10.1. Sample Size 
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A thorough neuropsychological examination may take two to six 
hours. While such lengthy testing is necessary for a comprehensive 
understanding a person's cognitive status, it becomes impractical 
for screening a large sample (Peyser et al., 1990). Time and 
resources meant that only ten people were included in the study, 
creating statistical limitations to the generalization of findings. 
While in a disease as heterogeneous as MS, it is important also to 
rely on in-depth, qualitative assessments, it is equally important 
to generate quantitative data on a larger sample. 
4.10.2. MCMI-II 
In this research, what was apparent, was the consistent and 
generalized psychological distress and disturbance amongst almost 
the entire sample in this study, with the means for both the MCMI-
II anxiety and dysthymia scales elevated above the "clinical 
cutoff" point. However, it is important to remember that in 
interpreting these score results, that there is a tendency towards 
overpathologization. 
Understandably, people with MS tend to be more acutely sensitive to 
bodily changes and more preoccupied with bodily functioning. Much 
of the criteria for anxiety and depression are based on somatic 
symptoms, allowing for significantly greater frequency of response 
in a "pathological" direction in an MS population. Some 
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researchers (Minden & Schiffer, 1993) thus suggest that such 
variables (fatigue, slowed thinking and poor concentration) should 
be excluded from the diagnostic criteria of depression in people 
with multiple sclerosis. 
4.10.3. Relapsing Remitting versus Chronic Progressive 
People with both RR and CP MS were included, despite the 
considerable evidence that cognitive dysfunction is particularly 
associated with a CP disease course. However, it is often unclear 
whether patients present a CP or RR course (Anzola et al., 1990). 
Longitudinal adherence to a disease type in MS is highly variable 
(Jennekens-Schinkel et al., 1990a), meaning that correlation with 
disease type and other disease-related variable may be expected to 
vary as time passes . A month after the study, one of the subjects 
phoned the researcher to say that her neurologist had re-classified 
her as having a CP course, and that she had "probably had it for 
ages!". 
4.10.4. Future Research 
Ideally, variables such as type of MS, whether or not in an active 
exacerbation, physical disability, disease duration, education, 
other cerebral trauma, medication, substance abuse, fatigue, pain 
and practice effects would be controlled. This study shows the 
necessi ty of a multifactorial aetiological model. In larger 
studies, multiple regression analysis could control these factors 
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individually, leading to causative associations between the 
variables. 
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APPENDIX 1 
A B B REV I A T ION S 
LIST OF ABBREVIATIONS 
In the Text: 
APA American Psychiatric Association 
CNS Central Nervous System 
CP Chronic Progressive (course of multiple sclerosis) 
MDE Major Depressive Episode 
MRI Magnetic Resonance Imaging 
MS Multiple Sclerosis 
RR Relapsing Remitting (course of multiple sclerosis) 
MHI-related abbreviations: 
CC Corpus Callosum 
PD Proton Density 
LLA Left (hemisphere) Lesion Area (of all plaques) 
LNL Left Number of Lesions 
LPD Left Plaque Diameter 
RLA Right (hemisphere) Lesion Area 
RNL Right Number of Lesions 
RPD Right Plaque Diameter 
SE Spin Echo 
TLA Total (left and right hemispheres together) Lesion Area 
TNL Total Number of Lesions 
TPD Total Plaque Diameter (summed diameter of all plaques) 
Questionnaires and Tests: 
BDI 
BRS 
COWAT 
DB 
DD 
DF 
DR 
DSIR 
DSS 
FSIQ 
GHQ 
GPT 
HBVR 
HRS 
IQ 
LM 
MCMI 
MMSE 
Beck Depression Inventory 
Base Rate Score 
Controlled Oral Word Association Test 
Digits Backward 
Digits Difference 
Digits Forward 
Digit Repetition 
Digit Symbol Incidental Recall 
Digit Supraspan 
Full Scale Intelligence Quotient 
General Health Questionnaire 
Grooved Pegboard Test 
Hopkins Board of Visual Recall 
Hamilton Rating Scale for Depression 
Intelligence Quotient 
Logical Memory 
Millon Clinical Multiaxial Inventory 
Mini Mental State Examination 
Questionnaires and Tests (continued): 
PIQ 
RAVLT 
RFIT 
ROCF 
RWFVS 
SAWAIS 
SS 
TMT 
WB 
WF 
VIQ 
~S 
VSS 
WCST 
WMS-R 
-X 
SD 
N 
Performance Intelligence Quotient 
Rey Auditory Verbal Learning Task 
Rey Fifteen Item Test 
Rey-Osterrieth Complex Figure 
Renfrew Word Finding Vocabulary Scale 
South African Wechsler Adult Intelligence Scale 
Supraspan 
Trail Making Test 
Visual Digits Backward 
Visual Digits Forward 
Verbal Intelligence Quotient 
Visual Memory Span 
Visual Supraspan 
Wisconsin Card Sorting Task 
Wechsler Memory Scale - Revised 
Mean 
Standard Deviation 
Number of participants in a sample 
Places. Organizations and Institutions: 
CSD 
GSH 
MRC 
RSA 
SANMSS 
Centre for Science Development 
Groote Schuur Hospital 
Medical Research Council of South Africa 
Republic of South Africa 
South African National Multiple Sclerosis Society 
APPENDIX 11 
THE 
N E U R 0 P S Y CHI A T RIC 
I N T E R V lEW 
L 
NEUROPSYCHIATRIC INTERVIEW: 
1) NAME (TITLE): 
2) DOB: 
3) AGE: 
4) GENDER: 
5) OCCUPATION: 
6) YEARS OF EDUCATION: 
7) HIGHEST EDUCATION: 
8) MARITAL STATUS: 
9) CHILDREN: 
10) LIVES WITH: 
11) ADDRESS : 
12) TELEPHONE NUMBER : 
13) HOME LANGUAGE: 
14) DO YOU HAVE MS? 
15) CHRONIC? ACUTE? OTHER? DON'T KNOW? 
16) WHEN WERE YOU DIAGNOSED? 
17) FROM WHEN CAN YOU REMEMBER YOUR FIRST MS SYMPTOMS? 
18) WHAT ARE YOUR CURRENT COMPLAINTS? 
19) WHAT DOES THE WORD "COGNITIVE" MEAN? 
20) WHAT ARE YOUR COGNITIVE COMPLAINTS? 
21) HISTORY OF COGNITIVE COMPLAINTS? (CHRONIC? COMES/GOES?) 
22) CURRENT MOOD? 
23) AFFECTIVE HISTORY? 
24) CONTEXT OF COGNITIVE COMPLAINTS? 
25) WHAT MAKES COGNITION WORSE? BETTER? 
26) EFFECTS OF COGNITIVE PROBLEMS: 
(a) ON SELF ESTEEM 
(b) ON FAMILY 
(e) ON WORK 
(d) ON ATTITUDE TOWARDS THE FUTURE 
27) WHAT DO YOU DO TO HELP YOURSELF COGNITIVELY? 
28) WHAT MAKES YOU THINK YOUR COGNITIVE PROBLEMS ARE CAUSED BY 
THE MS? 
29) WHEN DID YOU FIRST FIND OUT THAT MS COULD COGNITIVE 
PROBLEMS? WERE YOU TOLD TO EXPECT THEM? 
30) HOW DID THIS MAKE YOU FEEL? 
31) HOW DOES PARTICIPATION IN RESEARCH MAKE YOU FEEL? 
32) WHAT DO YOU EXPECT YOUR RESULTS MAY INDICATE? 
33) DO OTHERS ALSO FEEL YOUR COGNITIVE PROBLEMS ARE DUE TO THE 
MS? 
34) WHAT ELSE MAY BE CONTRIBUTING TO YOUR COGNITIVE PROBLEMS? 
35) FAMILY MEDICAL AND PSYCHIATRIC HISTORY: 
36) HEAD INJURIES? LOC? PT'S MHx? PSYCHIATRIC Hx? 
37) MEDICATION? PSYCHOTHERAPY? 
38) SCHOOL HISTORY? 
39) OCCUPATIONAL HISTORY? 
40) BASIC PERSONALITY? 
41) LEVEL OF FUNCTIONING? 
42) DEPRESSION INVENTORY AND MSE 
